Zydus Lifesciences Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release

04 Jul 2024

Zydus receives tentative approval from USFDA for Azilsartan Medoxomil Tablets, 40 mg and 80 mg.

Source: BSE India

View all announcements for Zydus Lifesciences Ltd